These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6786730)

  • 1. Evaluation of a protective environment in the management of granulocytopenic patients: a comparative study.
    Ribas-Mundo M; Granena A; Rozman C
    Cancer; 1981 Jul; 48(2):419-24. PubMed ID: 6786730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative randomized study of protected environment plus oral antibiotics versus oral antibiotics alone in neutropenic patients.
    Lohner D; Debusscher L; Prévost JM; Klastersky J
    Cancer Treat Rep; 1979 Mar; 63(3):363-8. PubMed ID: 106963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the value of simple protective isolation in patients with granulocytopenia.
    Nauseef WM; Maki DG
    N Engl J Med; 1981 Feb; 304(8):448-53. PubMed ID: 7005682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.
    Schimpff SC; Greene WH; Young VM; Fortner CL; Cusack N; Block JB; Wiernik PH
    Ann Intern Med; 1975 Mar; 82(3):351-8. PubMed ID: 1054222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges.
    Pizzo PA
    Cancer; 1984 Dec; 54(11 Suppl):2649-61. PubMed ID: 6437658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of ofloxacin in granulocytopenic patients with hematological malignancies during post-remission chemotherapy.
    Tsutani H; Imamura S; Ueda T; Yoshida H; Iwasaki H; Fukushima T; Yoshimura T; Toyooka S; Nakamura T
    Intern Med; 1992 Mar; 31(3):319-24. PubMed ID: 1611181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The problem of infections in acute leukemias: origin, therapy and prevention by protective isolation].
    Delsignore R; Baroni MC; Rizzoli V; Quaini F; Mangoni L; Butturini U
    Ateneo Parmense Acta Biomed; 1977; 48(5):381-403. PubMed ID: 418788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.
    Levine AS; Siegel SE; Schreiber AD; Hauser J; Preisler H; Goldstein IM; Seidler F; Simon R; Perry S; Bennett JE; Henderson ES
    N Engl J Med; 1973 Mar; 288(10):477-83. PubMed ID: 4630706
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin.
    Dennig D; Fülle HH; Hellriegel KP
    Onkologie; 1987 Feb; 10(1):57-8. PubMed ID: 3295628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia.
    Gomez-Villagran JL; Torres-Gómez A; Gomez-Garcia P; Martinez-Guibelalde F; Velasco-Jimena F
    Cancer; 1984 Aug; 54(4):734-8. PubMed ID: 6378355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of fever, granulocytopenia and antimicrobial therapy to bacteremia in cancer patients.
    Gill FA; Robinson R; Maclowry JD; Levine AS
    Cancer; 1977 Apr; 39(4):1704-9. PubMed ID: 856452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study on the value of selective decontamination of the digestive tract in acute leukemia patients (author's transl)].
    Jehn U; Ruckdeschel G; Sauer H; Clemm C; Wilmanns
    Klin Wochenschr; 1981 Oct; 59(19):1093-9. PubMed ID: 6808225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections in cancer patients on a protected environment-prophylactic antibiotic program.
    Bodey GP; Rodriguez V
    Am J Med; 1975 Oct; 59(4):497-504. PubMed ID: 810021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with protective isolation for infection prevention in the compromised host.
    Nagao T
    Tokai J Exp Clin Med; 1986; 11 Suppl():23-8. PubMed ID: 3132751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia.
    Curtis JE; Hasselback R; Bergsagel DE
    Can Med Assoc J; 1977 Aug; 117(4):341-5. PubMed ID: 407998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
    Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
    Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia.
    Feng X; Ruan Y; He Y; Zhang Y; Wu X; Liu H; Liu X; He L; Li C
    Acta Haematol; 2014; 132(1):112-7. PubMed ID: 24525963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of infection in 41 patients with idiosyncratic drug-induced agranulocytosis.
    D'Antonio D; Iacone A; Fioritoni G; Di Bartolomeo P; Torlontano G
    Ann Hematol; 1991 Aug; 63(2):84-8. PubMed ID: 1912036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes.
    Winston DJ; Ho WG; Gale RP
    Ann Intern Med; 1982 Oct; 97(4):509-15. PubMed ID: 6751183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of studies on protected environments and prophylactic antibiotics in adult acute leukemia.
    Levine AS; Robinson RA; Hauser JM
    Eur J Cancer (1965); 1975 Aug; 11suppl():57-66. PubMed ID: 815093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.